Bookbuilding IPO | ₹240 Cr | Listing at BSE, NSE |
SEBI has approved the Initial Public Offer (IPO) of Medicap Healthcare Ltd. on January 23, 2026. The company will proceed with next steps to launch the Initial Public Offer (IPO) subject to market conditions and other approvals. The SEBI approval is valid for 12 months.
Medicap Healthcare Ltd. IPO is a Book Build Issue of ₹240.00 crores consisting solely of fresh issue of shares with no offer for sale component.
The equity shares are proposed to be listed on NSE and BSE. Aryaman Financial Services Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. Key details like IPO dates, IPO price bands and lot size are yet to be announced.
Refer to Medicap Healthcare IPO DRHP for more details.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | |
| Lot Size | |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | [.] shares (agg. up to ₹240 Cr) |
| Fresh Issue | [.] shares (agg. up to ₹240 Cr) |
| Share Holding Pre Issue | 2,45,00,000 shares |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Mon, Sep 22, 2025 |
| SEBI/Exchange approval received | Fri, Jan 23, 2026 |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII Shares Offered | Not less than 15% of the Net Issue |
Incorporated on 2 June 2017, Medicap Healthcare Limited is in pharmaceutical packaging sector specializes in the production of pharmaceutical closures, including Euro Head caps and bottle preforms.
The company manufactures pharmaceutical packaging solutions, especially closures (e.g. Euro Head caps), Blood Collection Tubes (BCT), and components for Water for Injection (WFI) supply. It supplies pharma and healthcare industries.
The company operates from a 6,732 sq ft ultra-modern, state-of-the-art manufacturing facility with the latest technology.
Product Offerings:
As on August 31, 2025, the company had 66 permanent employees.
Competitive Strengths:
Medicap Healthcare Ltd.'s revenue increased by 7% and profit after tax (PAT) rose by 11% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 216.29 | 105.89 | 98.35 |
| Total Income | 109.91 | 103.05 | 72.60 |
| Profit After Tax | 26.62 | 23.90 | 14.79 |
| EBITDA | 37.16 | 35.68 | 22.67 |
| NET Worth | 110.84 | 84.21 | 60.32 |
| Total Borrowing | 88.09 | 6.98 | 26.77 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Purchase of plant and machinery for the existing Manufacturing Unit | 74.37 |
| 2 | Repayment or pre-payment, in full or part, of certain borrowings availed by the Company | 32.90 |
| 3 | Further Investment in the Subsidiary KASR Healthcare Private Limited for Repayment or pre-payment, in full or part, of certain borrowings availed by the Subsidiary Company | 52.80 |
| 4 | General Corporate Purposes |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 27.30% |
| ROCE | 17.67% |
| Debt/Equity | 0.67 |
| RoNW | 24.02% |
| PAT Margin | 24.58% |
| EBITDA Margin | 34.31% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 98% |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Fees payable to the BRLM and commissions (including underwriting commission, brokerage and selling commission, as applicable) | |
| 2 | Commission/processing fee for SCSBs, Banker(s) to the Issue and fee payable to the Sponsor Bank for Bids made by RIIs and Eligible Employees. Brokerage, underwriting commission and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | |
| 3 | Fees payable to Registrar to the Issue | |
| 4 | Fees payable to other advisors to the Issue (including statutory auditors, industry expert and independent chartered accountant) | |
| 5 | Others | |
| 6 | Listing fees, SEBI filing fees, upload fees, BSE and NSE processing fees, book building software fees and other regulatory expenses | |
| 7 | Printing and distribution of stationery | |
| 8 | Fees payable to legal counsel | |
| 9 | Advertising and marketing expenses | |
| 10 | Miscellaneous |
Lead Manager Reports
Medicap Healthcare IPO is a main-board IPO of 0 equity shares of the face value of ₹10 aggregating up to ₹240 Crores. The issue is priced at To be declared. The minimum order quantity is .
The Medicap Healthcare IPO open and close dates are not available as of now.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Medicap Healthcare IPO using UPI as a payment gateway. Zerodha customers can apply in Medicap Healthcare IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Medicap Healthcare IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Medicap Healthcare IPO dates are not announced. Please check back again after some time.
Medicap Healthcare IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Medicap Healthcare IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Medicap Healthcare IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Medicap Healthcare IPO allotment status.
The Medicap Healthcare IPO listing date is not yet announced. The tentative date of listing is .
